In addition, loss of IGF2BP3 or PDPN inhibits the expression of interleukin (IL-6) and IL-8 in OSCC cells and decreases the expression of NF-KB ligand receptor activator in OSCC xenograft tumor tissues (35). This evidence concerns the gene IGF2BP3 and neoplasm.